https://www.nytimes.com/2026/01/02/climate/glyphosate-roundup-retracted-study.html
maybe it’s not such a great idea to bathe our ready-to-harvest wheat (USA) in Roundup just to dry it out faster for processing.
the journal failed to notice in peer review that studies showing connections to cancer were simply not included. monsanto sponsored studies are golden though. this should have been caught in peer review and denied publication. instead, industry has its way for the last 25 years while relying on a review paper that is straight up fraud. monsanto ees wrote part of the paper and were not disclosed as authors.
i’m so grateful that the pharmaceutical industry, journals, researchers, and regulators are above such collusion and fraud. their doctors and scientists aren’t unduly influenced by any base motives. your pills and shots are all good, safe and effective.
“The 2000 paper, a scientific review conducted by three independent scientists, was for decades cited by other researchers as evidence of Roundup’s safety. It became the cornerstone of regulations that deemed the weedkiller safe.
But since then, emails uncovered as part of lawsuits against the weedkiller’s manufacturer, Monsanto, have shown that the company’s scientists played a significant role in conceiving and writing the study.”
“In the emails, Monsanto employees praised each other for their “hard work” on the paper, which included data collection, writing and review. One Monsanto employee expressed hope that the study would become “‘the’ reference on Roundup and glyphosate safety.” The pharmaceutical giant Bayer acquired Monsanto in 2018 for $63 billion.”
“Laboratory tests first flagged potential risks posed by exposure to glyphosate as far back as the early 1980s, and soon after, studies of Midwestern farmers exposed to herbicides started to show an increase in certain cancers. A U.S.-backed effort to eradicate coca fields in Colombia by spraying glyphosate from planes onto hundreds of thousands of acres of cropland led to widespread reports of illnesses among residents.
The 2000 paper declaring glyphosate safe was published against that backdrop.”
“The retraction points to a wider problem of research secretly funded by industries like tobacco and lead, said David Rosner, co-director of the Center for the History and Ethics of Public Health at Columbia University. “Shading the science to favor the corporate interest,” he said, was likely “the rule rather than the exception.” Journals needed to “press scientists more forcefully to identify conflicts of interest,” he said. “Huge financial interests are at stake.””
“What was surprising, they said, was that other researchers continued to cite the 2000 paper even after the emails were disclosed in litigation, starting in 2017. “This paper has been one of the most cited papers ever written on the topic of glyphosate safety,” Professor Oreskes said.”